Figure 3. [Secondary Prevention in Patients with Very High-Risk ASCVD ()]. - Endotext

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.

Endotext [Internet].

Show details

Figure 3.

Secondary Prevention in Patients with Very High-Risk ASCVD (1)

From: Guidelines for the Management of High Blood Cholesterol

This electronic version has been made freely available under a Creative Commons (CC-BY-NC-ND) license. A copy of the license can be viewed at http://creativecommons.org/licenses/by-nc-nd/2.0/.

Contents

Views

Cite this Page
Grundy SM, Feingold KR. Guidelines for the Management of High Blood Cholesterol. [Updated 2022 May 28]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Figure 3. [Secondary Prevention in Patients with Very High-Risk ASCVD ()].

Related information

PMC
PubMed Central citations
PubMed
Links to PubMed

Similar articles in PubMed

Review Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.[Curr Diab Rep. 2019]
Review Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD. Curr Diab Rep. 2019 Nov 21; 19(12):146. Epub 2019 Nov 21.
Review 2017 Taiwan lipid guidelines for high risk patients.[J Formos Med Assoc. 2017]
Review 2017 Taiwan lipid guidelines for high risk patients.
Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, et al. J Formos Med Assoc. 2017 Apr; 116(4):217-248. Epub 2017 Feb 24.
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.[J Am Coll Cardiol. 2017]
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.
Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD Jr, DePalma SM, Minissian MB, Orringer CE, Smith SC Jr. J Am Coll Cardiol. 2017 Oct 3; 70(14):1785-1822. Epub 2017 Sep 5.
Review Evaluation and Treatment of Dyslipidemia in the Elderly.[Endotext. 2000]
Review Evaluation and Treatment of Dyslipidemia in the Elderly.
Streja E, Feingold KR. Endotext. 2000
Review Cholesterol Lowering Drugs.[Endotext. 2000]
Review Cholesterol Lowering Drugs.
Feingold KR. Endotext. 2000

See reviews...See all...

Recent Activity

Clear Turn Off Turn On

Figure 3. [Secondary Prevention in Patients with Very High-Risk ASCVD ()]. - End...
Figure 3. [Secondary Prevention in Patients with Very High-Risk ASCVD ()]. - Endotext

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on